Themis Medicare is an API manufacturer based in India. It holds one active US drug master file. Its filings concentrate with NAFDAC (NG), FDA (GH) and TMDA (TZ). Its GMP standing is certified by NAFDAC (NG), EMA and FDA (GH), among 6 authorities. Customs aggregates show $11.6M of exports covering 166 molecules to 25 destinations in 2025.
| Site | FDA FEI |
|---|---|
| Haridwar, India | Not on file |
| d c industrial estatevapi 396 195valsad, India | Not on file |
| Haridwar, Nigeria | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| NAFDAC (NG) | 14 | 3 |
| FDA (GH) | 14 | 1 |
| TMDA (TZ) | 1 | 1 |
| MINSA (CR) | 1 | None |
| EMA | None | 1 |
| CDSCO (India) | None | 1 |
| EAEU_EEC | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $1.2M | 11 |
| 2025 | Not reported | $11.6M | 25 |
| 2024 | Not reported | $8.3M | 22 |
| 2023 | Not reported | $20.4M | 21 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Themis Medicare comes back tiered against every other supplier able to file there.
Start for free